Headache: a biopsychological perspective.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000503:physiopathology; D001521:Behavior Therapy; D002560:Cerebrovascular Circulation; D004576:Electromyography; D005246:Feedback; D006261:Headache / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009119:Muscle Contraction; D010551:Personality; D011602:Psychophysiologic Disorders; D011674:Pulse; D012701:Serotonin / Q000627:therapeutic use; D013315:Stress, Psychological; D013699:Temporal Arteries / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D008996:Monoamine Oxidase Inhibitors; D014662:Vasoconstrictor Agents; D012701:Serotonin